In addition to inhibiting aberrantly expressed CPS1 in tumor cells, AT067-H09 and H3B-120 could inhibit hepatic CPS1 and block the urea cycle leading to hyperammonemia, which can cause irreversible brain injury [10]. Here, CPS1 is linked to Hyperammonemia.